Report Detail

Other Global Genital Herpes Research and Development Pipeline Market Growth (Status and Outlook) 2021-2026

  • RnM4298128
  • |
  • 30 March, 2021
  • |
  • Global
  • |
  • 115 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Genital Herpes Research and Development Pipeline Market Size 2021-2026
    • 2.1.2 Genital Herpes Research and Development Pipeline Market Size CAGR by Region
  • 2.2 Genital Herpes Research and Development Pipeline Segment by Type
    • 2.2.1 Acyclovir
    • 2.2.2 Aspidasept
    • 2.2.3 G-103
    • 2.2.4 GEN-003
    • 2.2.5 GV-2207
    • 2.2.6 HerpeCide-I
    • 2.2.7 HSV-529
    • 2.2.8 Pritelivir
    • 2.2.9 SB-105A10
  • 2.3 Genital Herpes Research and Development Pipeline Market Size by Type
    • 2.3.1 Global Genital Herpes Research and Development Pipeline Market Size Market Share by Type (2021-2026)
    • 2.3.2 Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Type (2021-2026)
  • 2.4 Genital Herpes Research and Development Pipeline Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Clinic
  • 2.5 Genital Herpes Research and Development Pipeline Market Size by Application
    • 2.5.1 Global Genital Herpes Research and Development Pipeline Market Size Market Share by Application (2021-2026)
    • 2.5.2 Global Genital Herpes Research and Development Pipeline Market Size Growth Rate by Application (2021-2026)

3 Genital Herpes Research and Development Pipeline Key Players

  • 3.1 Date of Key Players Enter into Genital Herpes Research and Development Pipeline
  • 3.2 Key Players Genital Herpes Research and Development Pipeline Product Offered
  • 3.3 Key Players Genital Herpes Research and Development Pipeline Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players Genital Herpes Research and Development Pipeline Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 Genital Herpes Research and Development Pipeline by Regions

  • 4.1 Genital Herpes Research and Development Pipeline Market Size by Regions (2021-2026)
  • 4.2 Americas Genital Herpes Research and Development Pipeline Market Size Growth (2021-2026)
  • 4.3 APAC Genital Herpes Research and Development Pipeline Market Size Growth (2021-2026)
  • 4.4 Europe Genital Herpes Research and Development Pipeline Market Size Growth (2021-2026)

5 Americas

  • 5.1 Americas Genital Herpes Research and Development Pipeline Market Size by Countries (2021-2026)
  • 5.2 Americas Genital Herpes Research and Development Pipeline Market Size by Type (2021-2026)
  • 5.3 Americas Genital Herpes Research and Development Pipeline Market Size by Application (2021-2026)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Genital Herpes Research and Development Pipeline Market Size by Regions
  • 6.2 APAC Genital Herpes Research and Development Pipeline Market Size by Type (2021-2026)
  • 6.3 APAC Genital Herpes Research and Development Pipeline Market Size by Application (2021-2026)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Genital Herpes Research and Development Pipeline by Countries (2021-2026)
  • 7.2 Europe Genital Herpes Research and Development Pipeline Market Size by Type (2021-2026)
  • 7.3 Europe Genital Herpes Research and Development Pipeline Market Size by Application (2021-2026)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Market Drivers, Challenges and Trends

  • 8.1 Market Drivers and Impact
    • 8.1.1 Growing Demand from Key Regions
    • 8.1.2 Growing Demand from Key Applications and Potential Industries
  • 8.2 Market Challenges and Impact
  • 8.3 Market Trends
  • 8.4 Market Ecosystem and Roles

9 Key Investors in Genital Herpes Research and Development Pipeline

  • 9.1 Company A
    • 9.1.1 Company A Company Details
    • 9.1.2 Company Description
    • 9.1.3 Companies Invested by Company A
    • 9.1.4 Company A Key Development and Market Layout
  • 9.2 Company B
    • 9.2.1 Company B Company Details
    • 9.2.2 Company Description
    • 9.2.3 Companies Invested by Company B
    • 9.2.4 Company B Key Development and Market Layout
  • 9.3 Company C
    • 9.3.1 Company C Company Details
    • 9.3.2 Company Description
    • 9.3.3 Companies Invested by Company C
    • 9.3.4 Company C Key Development and Market Layout
  • 9.4 Company D
  • 9.5 ……

10 Key Players Analysis

  • 10.1 AiCuris GmbH & Co. KG
    • 10.1.1 AiCuris GmbH & Co. KG Company Details
    • 10.1.2 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Product Offered
    • 10.1.3 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.1.4 AiCuris GmbH & Co. KG Main Business Overview
    • 10.1.5 AiCuris GmbH & Co. KG News
  • 10.2 AlphaVax, Inc.
    • 10.2.1 AlphaVax, Inc. Company Details
    • 10.2.2 AlphaVax, Inc. Genital Herpes Research and Development Pipeline Product Offered
    • 10.2.3 AlphaVax, Inc. Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.2.4 AlphaVax, Inc. Main Business Overview
    • 10.2.5 AlphaVax, Inc. News
  • 10.3 Foamix Pharmaceuticals Ltd.
    • 10.3.1 Foamix Pharmaceuticals Ltd. Company Details
    • 10.3.2 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Product Offered
    • 10.3.3 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.3.4 Foamix Pharmaceuticals Ltd. Main Business Overview
    • 10.3.5 Foamix Pharmaceuticals Ltd. News
  • 10.4 Genocea Biosciences, Inc.
    • 10.4.1 Genocea Biosciences, Inc. Company Details
    • 10.4.2 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Product Offered
    • 10.4.3 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.4.4 Genocea Biosciences, Inc. Main Business Overview
    • 10.4.5 Genocea Biosciences, Inc. News
  • 10.5 GenVec, Inc.
    • 10.5.1 GenVec, Inc. Company Details
    • 10.5.2 GenVec, Inc. Genital Herpes Research and Development Pipeline Product Offered
    • 10.5.3 GenVec, Inc. Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.5.4 GenVec, Inc. Main Business Overview
    • 10.5.5 GenVec, Inc. News
  • 10.6 Immune Design Corp.
    • 10.6.1 Immune Design Corp. Company Details
    • 10.6.2 Immune Design Corp. Genital Herpes Research and Development Pipeline Product Offered
    • 10.6.3 Immune Design Corp. Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.6.4 Immune Design Corp. Main Business Overview
    • 10.6.5 Immune Design Corp. News
  • 10.7 Immunovaccine, Inc.
    • 10.7.1 Immunovaccine, Inc. Company Details
    • 10.7.2 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Product Offered
    • 10.7.3 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.7.4 Immunovaccine, Inc. Main Business Overview
    • 10.7.5 Immunovaccine, Inc. News
  • 10.8 Mymetics Corporation
    • 10.8.1 Mymetics Corporation Company Details
    • 10.8.2 Mymetics Corporation Genital Herpes Research and Development Pipeline Product Offered
    • 10.8.3 Mymetics Corporation Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.8.4 Mymetics Corporation Main Business Overview
    • 10.8.5 Mymetics Corporation News
  • 10.9 NanoBio Corporation
    • 10.9.1 NanoBio Corporation Company Details
    • 10.9.2 NanoBio Corporation Genital Herpes Research and Development Pipeline Product Offered
    • 10.9.3 NanoBio Corporation Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.9.4 NanoBio Corporation Main Business Overview
    • 10.9.5 NanoBio Corporation News
  • 10.10 NanoViricides, Inc.
    • 10.10.1 NanoViricides, Inc. Company Details
    • 10.10.2 NanoViricides, Inc. Genital Herpes Research and Development Pipeline Product Offered
    • 10.10.3 NanoViricides, Inc. Genital Herpes Research and Development Pipeline Market Size (2021 VS 2026)
    • 10.10.4 NanoViricides, Inc. Main Business Overview
    • 10.10.5 NanoViricides, Inc. News
  • 10.11 PaxVax
  • 10.12 Profectus BioSciences, Inc.
  • 10.13 Sanofi Pasteur SA
  • 10.14 Spider Biotech
  • 10.15 Starpharma Holdings Limited
  • 10.16 Vaccibody AS
  • 10.17 Vaxart, Inc.
  • 10.18 Vical Incorporated.

11 Research Findings and Conclusion

According to this study, over the next five years the Genital Herpes Research and Development Pipeline market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2026, from $ xx million in 2020.Specially this report presents the global revenue market share of key companies in Genital Herpes Research and Development Pipeline business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Genital Herpes Research and Development Pipeline market by product type, application, key manufacturers and key regions and countries.

Segmentation by product type:
Acyclovir
Aspidasept
G-103
GEN-003
GV-2207
HerpeCide-I
HSV-529
Pritelivir
SB-105A10

Segmentation by Application:
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
AiCuris GmbH & Co. KG
AlphaVax, Inc.
Foamix Pharmaceuticals Ltd.
Genocea Biosciences, Inc.
GenVec, Inc.
Immune Design Corp.
Immunovaccine, Inc.
Mymetics Corporation
NanoBio Corporation
NanoViricides, Inc.
PaxVax
Profectus BioSciences, Inc.
Sanofi Pasteur SA
Spider Biotech
Starpharma Holdings Limited
Vaccibody AS
Vaxart, Inc.
Vical Incorporated.


Summary:
Get latest Market Research Reports on Genital Herpes Research and Development Pipeline. Industry analysis & Market Report on Genital Herpes Research and Development Pipeline is a syndicated market report, published as Global Genital Herpes Research and Development Pipeline Market Growth (Status and Outlook) 2021-2026. It is complete Research Study and Industry Analysis of Genital Herpes Research and Development Pipeline market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,500.00
$7,000.00
2,545.14
5,090.29
2,935.98
5,871.95
383,124.00
766,248.00
262,351.25
524,702.50
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report